Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control (Q72544075)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

I. Peacock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6130198

10 August 2023

R. B. Tattersall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6130198

10 August 2023

A. Taylor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6130198

10 August 2023

C. A. Douglas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6130198

10 August 2023

W. G. Reeves

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6130198

10 August 2023

language of work or name

English

0 references

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

22 January 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6130198

full work available at URL

10 August 2023

https://api.elsevier.com/content/article/PII:S0140673683927563?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

https://api.elsevier.com/content/article/PII:S0140673683927563?httpAccept=text/plain

10 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

10 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

149-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

Circulating insulin-binding antibodies

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

An immunochemical method for the quantitation of insulin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Effects of zinc ion on the conformation of antigenic determinants on insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Immunoglobulin G-Insulin Antibodies and Immune Region-Associated Alloantigens in Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Clinical trial with monocomponent lente insulins. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Comparative Trials with Monocomponent (MC) and Monospecies (MS) Pork Insulins in the Treatment of Diabetes mellitus. Influence on Antibody Levels, on Insulin Requirement and on Some Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Effect of "fractionated" insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

The effect of insulin antibodies on insulin dose and diabetic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Plasma proinsulin-like material in insulin treated diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Concentration of Porcine Proinsulin-Like Material in Plasma of Insulin-Treated Diabetics in Relation to Purity of Insulin Preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Insulin in blood and insulin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Effect of insulin antibodies on free and total plasma-insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

DISAPPEARANCE OF I-131-LABELED INSULIN FROM PLASMA AS A GUIDE TO MANAGEMENT OF DIABETES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2992756-3

7 January 2021

Autoimmunity in diabetics induced by hormonal contaminants of insulin

3

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

C-peptide antibodies induced by bovine insulin therapy

10 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

Insulin antibodies induced by bovine insulin therapy

10 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

Adjuvant and suppressor activity of the polycation protamine hydrochloride in the primary immune response of mice

10 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(83)92756-3

10 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6130198%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference